Freesemann A G, Hofweber K, Doss M O
Abteilung für Klinische Biochemie, Fachbereich Humanmedizin und Klinikum, Philipps-Universität, Marburg, Germany.
Eur J Clin Chem Clin Biochem. 1997 Jan;35(1):35-9. doi: 10.1515/cclm.1997.35.1.35.
A hitherto undescribed dual deficiency of uroporphyrinogen III synthase and uroporphyrinogen decarboxylase was observed in the erythrocytes in a 14 year-old patient who had presented with congenital erythropoietic porphyria since early childhood. Whereas congenital erythropoietic porphyria was metabolically and clinically overt, a hereditary deficiency of uroporphyrinogen decarboxylase was confirmed by family study. The uroporphyrinogen III synthase activity of the propositus was decreased to 26% of the control while his asymptomatic family members had activities between 53-65% of the control. Additionally, the uroporphyrinogen decarboxylase activity was 55-66% of the control in the patient and his family. Family investigations have shown that the two disorders do not consistently segregate together. Although urinary porphyrin excretions of relatives were in the physiological range, the proportion of coproporphyrin isomer I showed a relative increase, which can serve as a biochemical indicator for heterozygous uroporphyrinogen III synthase gene carriers.
在一名自幼儿期就患有先天性红细胞生成性卟啉病的14岁患者的红细胞中,观察到一种此前未被描述的尿卟啉原III合酶和尿卟啉原脱羧酶双重缺陷。虽然先天性红细胞生成性卟啉病在代谢和临床上较为明显,但通过家族研究证实存在尿卟啉原脱羧酶的遗传性缺陷。先证者的尿卟啉原III合酶活性降至对照值的26%,而其无症状的家庭成员的活性在对照值的53%至65%之间。此外,患者及其家族中尿卟啉原脱羧酶活性为对照值的55%至66%。家族调查表明,这两种病症并非始终一起分离。尽管亲属的尿卟啉排泄量在生理范围内,但粪卟啉异构体I的比例显示相对增加,这可作为尿卟啉原III合酶基因杂合携带者的生化指标。